Market Research Logo

Global Hemophilia A Therapeutics Market 2019-2023

Global Hemophilia A Therapeutics Market 2019-2023

About this market

Emerging novel convenient approaches to drive market growth. Several novel therapies are emerging in the global hemophilia A therapeutics market. These therapies offer long lasting therapeutics benefits and some of the m possess potential to cure this disorder. Technavio’s analysts have predicted that the hemophilia A therapeutics market will register a CAGR of almost 7% by 2023.

Market Overview

Rising prevalence of hemophilia A

Hemophilia A is a rare genetic disorder, and the incidence of this disorder is gradually increasing. Hemophilia A accounts for about 80% of cases globally and mainly affects men.

High costs of hemophilia A therapeutics

High costs associated with drugs that treat hemophilia A are one of the biggest challenges faced by the market.

For the detailed list of factors that will drive and challenge the growth of the hemophilia A therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Pfizer and Shire the competitive environment is quite intense. Factors such as the emerging novel convenient approaches and the rising prevalence of hemophilia A, will provide considerable growth opportunities to hemophilia A therapeutics manufactures. Bayer, CSL, Novo Nordisk, Pfizer, and Shire are some of the major companies covered in this report.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global rare disease market
      • Table Segments of global rare disease market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for hemophilia A
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Recombinant therapies - Market size and forecast 2018- 2023
      • Table Recombinant therapies - Market size and forecast 2018-2023 ($ millions)
      • Table Recombinant therapies - Year-over-year growth 2019-2023 (%)
    • Plasma-derived therapies - Market size and forecast 2018- 2023
      • Table Plasma-derived therapies - Market size and forecast 2018-2023 ($ millions)
      • Table Plasma-derived therapies - Year-over-year growth 2019-2023 (%)
    • Hormonal therapies - Market size and forecast 2018-2023
      • Table Hormonal therapies - Market size and forecast 2018-2023 ($ millions)
      • Table Hormonal therapies - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Market segmentation by type
    • On demand treatment
    • Prophylactic treatment
    • Inhibitor treatment
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Manufacturer Co-Pay Programs
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bayer
      • Table Bayer - Vendor overview
      • Table Bayer - Business segments
      • Table Bayer - Organizational developments
      • Table Bayer - Geographic focus
      • Table Bayer - Segment focus
      • Table Bayer - Key offerings
    • CSL
      • Table CSL - Vendor overview
      • Table CSL - Business segments
      • Table CSL - Organizational developments
      • Table CSL - Geographic focus
      • Table CSL - Segment focus
      • Table CSL - Key offerings
    • Novo Nordisk
      • Table Novo Nordisk - Vendor overview
      • Table Novo Nordisk - Business segments
      • Table Novo Nordisk - Organizational developments
      • Table Novo Nordisk - Geographic focus
      • Table Novo Nordisk - Segment focus
      • Table Novo Nordisk - Key offerings
    • Pfizer
      • Table Pfizer - Vendor overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
    • Shire
      • Table Shire - Vendor overview
      • Table Shire - Business segments
      • Table Shire - Organizational developments
      • Table Shire - Geographic focus
      • Table Shire - Key offerings
  • Appendix
    • Research methodology gy
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report